Anesthesia for Pars Plana Vitrectomy (PPV) With Insulin Needle

The recruitment status of this study is unknown because the information has not been verified recently.

Verified February 2010 by King Khaled Eye Specialist Hospital. Recruitment status was Recruiting

First Received on July 1, 2008. Last Updated on February 24, 2010 History of Changes

Sponsor:	King Khaled Eye Specialist Hospital
Information provided by:	King Khaled Eye Specialist Hospital
ClinicalTrials.gov Identifier:	NCT00735657

Purpose

Periocular blockade with 12.5 mm needle is as effective as block with 25 mm needle for patients undergoing Pars Plana Vitrectomy.

Condition	Intervention
Retinal Disorders	Device: needle Procedure: Pars Plana Vitrectomy

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Safety Study Intervention Model: Parallel Assignment Masking: Single Blind (Investigator) Primary Purpose: Treatment
Official Title:	Anesthesia for PPV Using Insulin Needle

Resource links provided by NLM:

MedlinePlus related topics: Diabetes Medicines Retinal Disorders

Drug Information available for: Insulin

U.S. FDA Resources

Further study details as provided by King Khaled Eye Specialist Hospital:

Primary Outcome Measures:

Efficacy of insulin needle. [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Estimated Enrollment:	120
Study Start Date:	August 2008
Estimated Study Completion Date:	December 2010
Estimated Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Active Comparator: Group 1 Control	Device: needle Peribulbar blockade with standard (25 mm) needle Other Name: Peribulbar blockade with standard needle Procedure: Pars Plana Vitrectomy Peribulbar block Other Name: Extraconal block
Active Comparator: Group 2 Block with short needle	Device: needle Peribulbar blockade with short (12.5 mm) needle Other Name: Peribulbar blockade with short needle Procedure: Pars Plana Vitrectomy Peribulbar block Other Name: Extraconal block

Detailed Description:

The author wants to see the effect of short needle in patients undergoing retinal surgery.

Eligibility

Ages Eligible for Study:	40 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Adult patients undergoing pars plana vitrectomy under local anesthesia

Exclusion Criteria:

Patients allergic to local anesthetic solutions
With local sepsis
Serious impairment of coagulation
Orbital abnormalities
Unable to cooperate in maintaining a relatively motionless supine position
Who refused the anesthetic technique

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00735657

Contacts

Contact: Waleed Riad, MD,AB,SB

0096614821234 ext 3215

waleed_riad@yahoo.com

Locations

Saudi Arabia
King Khaled Eye Specialist hospital	Recruiting
Riyadh, Saudi Arabia, 11462
Contact: Waleed Riad 0096614821234 ext 3215 waleed_riad@yahoo.com
Principal Investigator: Waleed Riad, MD, AB,SB

Sponsors and Collaborators

King Khaled Eye Specialist Hospital

Investigators

Principal Investigator:

Waleed Riad, MD

KKESH

More Information

No publications provided

Responsible Party:	Waleed Riad MD, King Khaled Eye Specialist Hospital
ClinicalTrials.gov Identifier:	NCT00735657 History of Changes
Other Study ID Numbers:	Rp0822
Study First Received:	July 1, 2008
Last Updated:	February 24, 2010
Health Authority:	Saudi Arabia: Ministry of Health

Keywords provided by King Khaled Eye Specialist Hospital:

Efficiency
Pars
Plana
Vitrectomy

Additional relevant MeSH terms:

Retinal Diseases
Eye Diseases
Anesthetics
Central Nervous System Depressants

Physiological Effects of Drugs
Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on February 09, 2012